Search for:
Enter your search term above.
About
About LCRF
People
Board of Directors
Scientific Advisory Board
Research Advocates
Education & Engagement Committee
Staff
Research partners
Financials
Careers
Press kit
Get Involved
Events calendar
Free to Breathe
Gala
Together Separately livestreams
Honor a memory
Financial giving
Donate
Other ways to give
What your gift can do
Let's connect!
Resources
Support line (844) 835-4325
Resources in English + español
Living with Lung Cancer
Biomarker Testing
Recursos en español
Symptoms + risk
Signs and symptoms
Women + Lung Cancer
Know Your Risk
After diagnosis
Stages of lung cancer
Clinical trials
Quick links
Together Separately livestreams
Lung cancer journeys
Share your story
Research
Why research?
Our investigators
Current funded projects
Research funding opportunities
Scientific updates
Lung Cancer Mutation Consortium
News
Close
Link back to homepage
Link back to homepage
About
About LCRF
People
Board of Directors
Scientific Advisory Board
Research Advocates
Education & Engagement Committee
Staff
Research partners
Financials
Careers
Press kit
Get Involved
Events calendar
Free to Breathe
Gala
Together Separately livestreams
Honor a memory
Financial giving
Donate
Other ways to give
What your gift can do
Let’s connect!
Resources
Support line (844) 835-4325
Resources in English + español
Living with Lung Cancer
Biomarker Testing
Recursos en español
Symptoms + risk
Signs and symptoms
Women + Lung Cancer
Know Your Risk
After diagnosis
Stages of lung cancer
Clinical trials
Quick links
Together Separately livestreams
Lung cancer journeys
Share your story
Research
Why research?
Our investigators
Current funded projects
Research funding opportunities
Scientific updates
Lung Cancer Mutation Consortium
News
In Honor
Subscribe
Give Now
Link to Open Side Menu
News
September 17, 2026
Eddie Collins 5K returns
September 15, 2026
Research summary: resistance to sevabertinib in HER2+ NSCLC
September 14, 2026
Sevabertinib for HER2+ lung cancer
September 13, 2026
18-month update: targeting mSWI/SNF in KRAS+ lung cancer
August 3, 2026
Zidesamtinib for ROS1+ NSCLC